Proficio Capital Partners LLC Buys New Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Proficio Capital Partners LLC purchased a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MDFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 30,780 shares of the company’s stock, valued at approximately $404,000.

Several other institutional investors and hedge funds also recently modified their holdings of MD. Quest Partners LLC raised its stake in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares in the last quarter. Parkside Financial Bank & Trust increased its stake in Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after buying an additional 1,040 shares during the period. Quarry LP raised its position in shares of Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after buying an additional 1,662 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock worth $91,000 after acquiring an additional 6,090 shares during the period. Finally, FMR LLC boosted its holdings in shares of Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after acquiring an additional 6,771 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Macquarie started coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Truist Financial raised their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, February 21st. Finally, UBS Group boosted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $17.08.

View Our Latest Analysis on MD

Pediatrix Medical Group Stock Performance

MD opened at $14.51 on Tuesday. The business has a fifty day simple moving average of $14.33 and a 200-day simple moving average of $13.58. The firm has a market cap of $1.25 billion, a PE ratio of -12.09, a P/E/G ratio of 1.74 and a beta of 1.49. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Pediatrix Medical Group (NYSE:MDGet Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. As a group, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Read More

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.